Russian Federation

6 Vaccines Approved for Use in Russian Federation

Protein Subunit

Vector State Research Center of Virology and Biotechnology

Aurora-CoV

Approved in 1 country
2 trials in 1 country
Approval Source: interfax.com
Protein Subunit

Vector State Research Center of Virology and Biotechnology

EpiVacCorona

Approved in 4 countries
4 trials in 1 country
Approval Source: cnbc.com
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
24 trials in 7 countries
Approval Source: theguardian.com
Non Replicating Viral Vector

Gamaleya

Sputnik Light

Approved in 26 countries
7 trials in 3 countries
Approval Source: rdif.ru
Inactivated

Chumakov Center

KoviVac

Approved in 3 countries
3 trials in 1 country
Approval Source: grls.rosminzdrav.ru
Non Replicating Viral Vector

Gamaleya

Gam-COVID-Vac

Approved in 1 country
2 trials in 0 countries
Approval Source: aninews.in

11 in Clinical Trials in Russian Federation

Protein Subunit

Vector State Research Center of Virology and Biotechnology

EpiVacCorona

Approved in 4 countries
4 trials in 1 country
Non Replicating Viral Vector

CanSino

Convidecia

Approved in 10 countries
13 trials in 6 countries
Non Replicating Viral Vector

Gamaleya

Sputnik Light

Approved in 26 countries
7 trials in 3 countries
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
24 trials in 7 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
64 trials in 31 countries
Protein Subunit

Human Stem Cell Institute Russia

Betuvax-CoV-2

2 trials in 1 country
Protein Subunit

St. Petersburg Research Institute of Vaccines and Sera

Recombinant subunit vaccine

2 trials in 1 country
Protein Subunit

Vector State Research Center of Virology and Biotechnology

Aurora-CoV

Approved in 1 country
2 trials in 1 country
Non Replicating Viral Vector

Biocad

BCD-250

2 trials in 1 country
Non Replicating Viral Vector

Institute of Vaccines and Medical Biologicals

COVIVAC

4 trials in 2 countries
Inactivated

Chumakov Center

KoviVac

Approved in 3 countries
3 trials in 1 country